EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Intent to Treat Analysis of the Primary and Secondary Outcomes for the ODINN Intact Fish Skin Graft for Deep Diabetic Foot Wounds Trial

Dured Dardari, Alberto Piaggesi, Louis Potier, Ariane Sultan, Holger Diener, Maud Francois, Bernhard Dorweiler, Benjamin Bouillet, Jocelyne M'Bemba, Lucy Chaillous, Giacomo Clerici, Laurence Kessler und 8 weitere

International Wound Journal · 2026

DOI: 10.1111/iwj.70847 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift International Wound Journal, 2026. Verfasst von Dured Dardari und 19 weiteren Autor:innen. Beteiligte Einrichtung: Diabetology Department, Center Hopitalier Sud Francilien, Corbeil-Essonnes, France. Hauptthemen laut MEDLINE: Diabetic Foot, Wound Healing, Skin Transplantation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Horizon 2020 research and innovation program, Kerecis LLC, Reykjavik IS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is a significant need for trials that evaluate the treatment of University of Texas (UT) grade 2 and 3 diabetic foot ulcers (bone, joint, or tendon exposed wounds). We undertook a trial looking at the effect of intact fish skin graft (IFSG) on these deep and difficult‐to‐heal ulcers. 262 patients Intent to Treat (ITT) patients with UT grade 2 and 3 DFUs were randomised to receive intact fish skin graft (IFSG) or a standardised treatment (SOC) that adhered to the International Working Group on the Diabetic Foot (IWGDF) guidelines. The secondary endpoints that were measured included wound area reduction (WAR), healing rates at 20 and 24 weeks; closure rates by UT grade, perfusion, quality of life, pain reduction and IFSG safety. We report ITT (all randomised) (mITT previosly reported) The (WAR) at 12 weeks was 65.53% for IFSG versus 30.82% for SOC ( p = 0.007). UT 2 wounds (60% of total) exhibited a closure rate of 47% versus 23% at 16 weeks for IFSG versus SOC ( p = 0.0033). Target wound infections were comparable (39 vs. 37) and major outcomes were comparable during the 24 week period (target‐limb amputations 8% vs. 7%). Time‐to‐heal favoured IFSG (restricted mean to 24 weeks 17.31 vs. 19.37 weeks; KM/log‐rank significant; Cox HR 1.59). The in the treatment of deep complex diabetic foot wounds the addition of IFSG significantly improved the number of patients with total wound closure as well as the time to wound closure without increased risk of complications. This improvement in total wound closure and time to wound closure was noted across prior amputation status, quality of perfusion, and UT grade.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic FootWound HealingSkin TransplantationHumansFemaleMaleAnimalsTreatment OutcomeMiddle AgedAgedFishesIntention to Treat Analysis

Autor:innen und Institutionen

  • Diabetology Department, Center Hopitalier Sud Francilien, Corbeil-Essonnes, France.
  • LBEPS, Université D'evry, IRBA, Université Paris Saclay, Orsay, France.
  • Diabetic Foot Section, Department of Endocrinology and Metabolism, University Hospital Pisa, Pisa, Italy.
  • Diabetology Department, CHU Bichat-Claude Bernard, AP-HP, Paris, France.
  • Institut Necker-Enfants Malades, Université Paris Cité, INSERM UMR-S1151, CNRS UMR-S8253, Paris, France.
  • Diabetology Nutrition Department, CHU Montpelier, Université de Montpellier, Montpellier, France.

ORCID-Profile: John C Lantis

Förderung

  • Horizon 2020 research and innovation program
  • Kerecis LLC, Reykjavik IS

Zitieren

APA

Dardari, D., Piaggesi, A., Potier, L., Sultan, A., Diener, H., Francois, M., Dorweiler, B., Bouillet, B., M'Bemba, J., Chaillous, L., Clerici, G., Kessler, L., Wetzel-Roth, W., Storck, M., Shi, D., Davidsson, O., Baldursson, B., Kjartansson, H., Charpentier, G., & Lantis, J. C. (2026). Intent to Treat Analysis of the Primary and Secondary Outcomes for the ODINN Intact Fish Skin Graft for Deep Diabetic Foot Wounds Trial. International Wound Journal. https://doi.org/10.1111/iwj.70847

Vancouver

Dardari D, Piaggesi A, Potier L, Sultan A, Diener H, Francois M, et al. Intent to Treat Analysis of the Primary and Secondary Outcomes for the ODINN Intact Fish Skin Graft for Deep Diabetic Foot Wounds Trial. International Wound Journal. 2026. doi:10.1111/iwj.70847

BibTeX
@article{Dardari2026,
  author = {Dardari, Dured and Piaggesi, Alberto and Potier, Louis and Sultan, Ariane and Diener, Holger and Francois, Maud and Dorweiler, Bernhard and Bouillet, Benjamin and M'Bemba, Jocelyne and Chaillous, Lucy and Clerici, Giacomo and Kessler, Laurence and Wetzel-Roth, Walter and Storck, Martin and Shi, Dereck and Davidsson, Olafur and Baldursson, Baldur and Kjartansson, Hilmar and Charpentier, Guillaume and Lantis, John C},
  title = {Intent to Treat Analysis of the Primary and Secondary Outcomes for the ODINN Intact Fish Skin Graft for Deep Diabetic Foot Wounds Trial},
  journal = {International Wound Journal},
  year = {2026},
  doi = {10.1111/iwj.70847}
}
Kostenlos starten →